Equillium (EQ) Amortization of Deferred Charges (2020 - 2023)
Equillium (EQ) reported Amortization of Deferred Charges of $150000.0 for Q2 2023, up 188.46% year-over-year from $52000.0 in Q2 2022, and up 400.0% quarter-over-quarter from $30000.0 in Q1 2023.
Equillium (EQ) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends
Equillium (EQ) has 4 years of Amortization of Deferred Charges data on file, last reported at $150000.0 in Q2 2023.
- Amortization of Deferred Charges for Q2 2023 came in at $150000.0, up 188.46% year-over-year; the trailing twelve-month figure through Dec 2023 was $180000.0 (down 11.33% YoY), and the FY2023 annual result was $180000.0, down 11.33% from the prior year.
- Amortization of Deferred Charges advanced to $150000.0 in Q2 2023 per EQ's latest filing, from $30000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $150000.0 in Q2 2023 and troughed at $30000.0 in Q1 2023.
- A 4-year average of $62857.1 and a median of $59000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
- On a YoY basis, Amortization of Deferred Charges climbed as much as 188.46% in 2023 and fell as far as 37.5% in 2023.
- A 4-year view of Amortization of Deferred Charges shows it stood at $65000.0 in 2020, then retreated by 15.38% to $55000.0 in 2021, then dropped by 7.27% to $51000.0 in 2022, then soared by 194.12% to $150000.0 in 2023.
- Business Quant data shows EQ's Amortization of Deferred Charges at $150000.0 in Q2 2023, $30000.0 in Q1 2023, and $51000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Mar 31, 2021 | 64,000.00 |